SMPDL3B and diabetic kidney disease: We previously demonstrated that, in podocytes, SMPDL3b binds to the soluble urokinase plasminogen activator receptor (suPAR) (40), which is reported to be elevated in sera from patients with FSGS and DKD among other causes of CKD [40,99,100].